EA200400807A1 - Композиция для лечения нейроцереброваскулярных нарушений - Google Patents
Композиция для лечения нейроцереброваскулярных нарушенийInfo
- Publication number
- EA200400807A1 EA200400807A1 EA200400807A EA200400807A EA200400807A1 EA 200400807 A1 EA200400807 A1 EA 200400807A1 EA 200400807 A EA200400807 A EA 200400807A EA 200400807 A EA200400807 A EA 200400807A EA 200400807 A1 EA200400807 A1 EA 200400807A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- composition
- fraction
- terribrovascular
- disturbances
- neural
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000001537 neural effect Effects 0.000 title 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- NAAJVHHFAXWBOK-ZDUSSCGKSA-N (+)-(S)-ar-turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CC=C(C)C=C1 NAAJVHHFAXWBOK-ZDUSSCGKSA-N 0.000 abstract 1
- CAULGCQHVOVVRN-UHFFFAOYSA-N (3Z,9E)-Germacra-3,7(11),9-trien-6-on Natural products CC(C)=C1CC=C(C)CCC=C(C)CC1=O CAULGCQHVOVVRN-UHFFFAOYSA-N 0.000 abstract 1
- CAULGCQHVOVVRN-SWZPTJTJSA-N (E,E)-germacrone Chemical compound CC(C)=C1C\C=C(C)\CC\C=C(C)\CC1=O CAULGCQHVOVVRN-SWZPTJTJSA-N 0.000 abstract 1
- 241000407170 Curcuma Species 0.000 abstract 1
- ZVSZHMFUICOVPY-UHFFFAOYSA-N Germacrone Natural products CC(=C)C1CC=C(/C)CCC=C(/C)CC1=O ZVSZHMFUICOVPY-UHFFFAOYSA-N 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- FZPYMZUVXJUAQA-ZDUSSCGKSA-N Turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-ZDUSSCGKSA-N 0.000 abstract 1
- FZPYMZUVXJUAQA-UHFFFAOYSA-N Turmerone Natural products CC(C)=CC(=O)CC(C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-UHFFFAOYSA-N 0.000 abstract 1
- 241000234299 Zingiberaceae Species 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 abstract 1
- XOCANRBEOZQNAQ-KGLIPLIRSA-N ar-turmerone Natural products C[C@H](CC(=O)C=C(C)C)[C@@H]1CC=C(C)C=C1 XOCANRBEOZQNAQ-KGLIPLIRSA-N 0.000 abstract 1
- -1 curcumerone Chemical compound 0.000 abstract 1
- 229940109262 curcumin Drugs 0.000 abstract 1
- 235000012754 curcumin Nutrition 0.000 abstract 1
- 239000004148 curcumin Substances 0.000 abstract 1
- ZVMJXSJCBLRAPD-UHFFFAOYSA-N curzerenone Chemical compound C1C(C=C)(C)C(C(=C)C)C(=O)C2=C1OC=C2C ZVMJXSJCBLRAPD-UHFFFAOYSA-N 0.000 abstract 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 abstract 1
- 210000002196 fr. b Anatomy 0.000 abstract 1
- 210000003918 fraction a Anatomy 0.000 abstract 1
- 210000000540 fraction c Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
Abstract
Данное изобретение относится к композиции, полученной из растворимого липидного экстракта корневищ и листьев видов Curcuma семейства Zingiberaceae, используемой для лечения нейроцереброваскулярных нарушений, указанная композиция содержит фракцию A, состоящую из ar-турмерона формулы (1) и турмерона формулы (2), и/или вместе с фракцией B, состоящей из куркумена и зингиберина, и/или фракцией C, состоящей из гермакрона, куркумерона, зедоарона, седоарондиола, изоздедоаронидиола, куркуменона и курлона, и/или фармацевтически приемлемые добавки, и к способу лечения нейроцереброваскулярных нарушений у животных, включая человека, с использованием указанной композиции, введением терапевтически эффективного количества растворимого липидного экстракта.Отчет о международном поиске был опубликован 2004.06.17.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34016501P | 2001-12-14 | 2001-12-14 | |
| PCT/IB2002/005366 WO2003051380A2 (en) | 2001-12-14 | 2002-12-14 | Compositions containeing curcuma extracts for the treatment of neurocerebrovascular disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200400807A1 true EA200400807A1 (ru) | 2004-12-30 |
| EA007067B1 EA007067B1 (ru) | 2006-06-30 |
Family
ID=23332163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200400807A EA007067B1 (ru) | 2001-12-14 | 2002-12-14 | Композиция для лечения нейроцереброваскулярных нарушений |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20060051438A1 (ru) |
| EP (1) | EP1453528B1 (ru) |
| JP (1) | JP4695839B2 (ru) |
| KR (1) | KR101001815B1 (ru) |
| CN (1) | CN100528149C (ru) |
| AU (2) | AU2002348802A1 (ru) |
| BR (1) | BR0214962A (ru) |
| CA (1) | CA2473874C (ru) |
| DE (1) | DE60233069D1 (ru) |
| EA (1) | EA007067B1 (ru) |
| EE (1) | EE05374B1 (ru) |
| GE (1) | GEP20084442B (ru) |
| LT (1) | LT5284B (ru) |
| LV (1) | LV13250B (ru) |
| MX (1) | MXPA04005680A (ru) |
| NO (1) | NO332066B1 (ru) |
| UA (1) | UA82057C2 (ru) |
| WO (1) | WO2003051380A2 (ru) |
| ZA (1) | ZA200404648B (ru) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2566202A1 (en) * | 2004-05-31 | 2005-12-08 | Kaneka Corporation | Agent for preventing/ameliorating life style-related diseases containing turmeric essential oil component |
| WO2006118079A1 (ja) * | 2005-04-28 | 2006-11-09 | Arata Yamasaki | 皮膚の老化防止剤 |
| US7883728B2 (en) | 2005-05-30 | 2011-02-08 | Arjuna Natural Extracts, Ltd. | Composition to enhance the bioavailability of curcumin |
| US10543277B2 (en) | 2005-05-30 | 2020-01-28 | Arjuna Natural Private Limited | Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof |
| US10286027B2 (en) | 2005-05-30 | 2019-05-14 | Arjuna Natural Extracts, Ltd. | Sustained release formulations of curcuminoids and method of preparation thereof |
| US12053438B2 (en) | 2005-05-30 | 2024-08-06 | Arjuna Natural Private Limited | Formulation of curcuminoids with enhanced bioavailability of curcumin, demethoxycurcumin, bisdemethoxycurcumin and method of preparation and uses thereof |
| PL1890546T3 (pl) | 2005-05-30 | 2019-04-30 | Benny Antony | Sposób poprawiania biodostępności kurkuminy |
| US8859020B2 (en) | 2005-05-30 | 2014-10-14 | Benny Antony | Treatment of alzheimer's with a curcuminoid mixture and essential oil of turmeric having 45% Ar-turmerone |
| US9492402B2 (en) | 2005-05-30 | 2016-11-15 | Benny Antony | Formulation of curcuminoids with enhanced bioavailability of curcumin, demethoxycurcumin, bisdemethoxycurcumin and method of preparation and uses thereof |
| JP4980626B2 (ja) * | 2006-02-28 | 2012-07-18 | ポーラ化成工業株式会社 | プラスミノーゲンアクチベーターインヒビターｉ阻害剤及びそれを配合してなる食品組成物 |
| JP5207341B2 (ja) * | 2006-10-26 | 2013-06-12 | 独立行政法人産業技術総合研究所 | 炎症性サイトカイン産生抑制剤 |
| JP5486744B2 (ja) * | 2007-10-03 | 2014-05-07 | サベル コーポレーション | ムユヨの花、トゲバンレイシの葉、及びウコンの根の抽出物を含む、肝炎を治療するための組成物 |
| CN102340990B (zh) * | 2009-03-05 | 2015-03-04 | 关键基因股份有限公司 | 基于r-姜黄烯的植物挥发性物质 |
| BR112012002246A2 (pt) * | 2009-07-31 | 2019-09-24 | Cognition Therapeutics Inc | composto, composto ou sal farmaceutico aceitavel deste, composição farmaceutica, metodo para inibir, tratar e/ou reduzir o declinio cognitivol e/ou doença de akzhmer em um paciente |
| JP5764288B2 (ja) * | 2009-09-24 | 2015-08-19 | ハウス食品グループ本社株式会社 | ウコン抽出物とガジュツ抽出物とを含有する組成物 |
| JP5578822B2 (ja) * | 2009-09-25 | 2014-08-27 | 株式会社ピカソ美化学研究所 | アセチルコリンエステラーゼ阻害剤 |
| WO2012106426A1 (en) | 2011-02-02 | 2012-08-09 | Cognition Therapeutics, Inc. | Isolated compounds from turmeric oil and methods of use |
| RU2599835C2 (ru) * | 2011-03-29 | 2016-10-20 | Каунсил Оф Сайнтифик Энд Индастриал Рисерч | Способ модификации эфирного масла curcuma aromatica |
| GB201111319D0 (en) | 2011-07-04 | 2011-08-17 | Univ Leuven Kath | Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa |
| KR101792031B1 (ko) * | 2012-01-13 | 2017-10-31 | 주식회사 엘지생활건강 | 피부 주름 개선 및 탄력 증진용 조성물 |
| CN102697757B (zh) * | 2012-05-18 | 2014-06-04 | 广州军区广州总医院 | 对羟基苄叉丙酮在制备预防和/或治疗脑病药物中的应用 |
| JP2014201528A (ja) * | 2013-04-02 | 2014-10-27 | クラシエ製薬株式会社 | 抗酸化剤 |
| MX368755B (es) | 2014-01-31 | 2019-10-15 | Cognition Therapeutics Inc | Composiciones de isoindolina y métodos para tratar una enfermedad neurodegenerativa. |
| CN104840451B (zh) * | 2014-09-23 | 2017-04-05 | 桂林八加一药业股份有限公司 | 一种用于治疗冠心病、高脂血症的中药有效部位、制备方法及从中分离有效成分的方法 |
| CN105738546B (zh) * | 2014-12-12 | 2020-01-21 | 桂林八加一药业股份有限公司 | 毛郁金药材指纹图谱的建立方法及其指纹图谱 |
| CN105055449B (zh) * | 2015-07-27 | 2019-08-09 | 中国科学院西北高原生物研究所 | 一种具有抗炎镇痛活性的塞隆骨提取物、制备方法及中药制剂 |
| CN106511784A (zh) * | 2016-12-29 | 2017-03-22 | 王明金 | 一种治疗精神疾病的中药组合物及其制备方法 |
| CN106492137A (zh) * | 2016-12-29 | 2017-03-15 | 王明金 | 一种治疗抑郁症的中药组合物及其制备方法 |
| CN106491996A (zh) * | 2016-12-29 | 2017-03-15 | 王明金 | 一种治疗狂躁症的中药组合物及其制备方法 |
| CN106491997A (zh) * | 2016-12-29 | 2017-03-15 | 王明金 | 一种抗精神障碍的中药组合物及其制备方法 |
| WO2018207910A1 (ja) * | 2017-05-12 | 2018-11-15 | ハウスウェルネスフーズ株式会社 | 抗炎症用組成物 |
| BR112019023851A2 (pt) | 2017-05-15 | 2020-08-18 | Cognition Therapeutics, Inc. | compostos, suas composições farmacêuticas e métodos para tratamento de doenças neurodegenerativas |
| US10391138B2 (en) * | 2017-07-11 | 2019-08-27 | Muniyal Ayurvedic Research Centre | Multidimensional approach for Cancer treatment |
| CN108498755B (zh) | 2018-04-17 | 2021-04-09 | 贾洪章 | 治疗心脑血管疾病的中药组合物及其制备方法和用途 |
| WO2020004357A1 (ja) * | 2018-06-29 | 2020-01-02 | ハウスウェルネスフーズ株式会社 | アルツハイマー病の治療、予防又は改善用組成物、脳神経細胞死の抑制用組成物、アミロイドβペプチドで誘導されるミクログリアの活性化の抑制用組成物、及び、アミロイドβペプチドで誘導されるＰＧＥ２、ＴＮＦ－α又はＩＬ－１β産生の抑制用組成物 |
| CN111617060A (zh) * | 2020-05-29 | 2020-09-04 | 广东工业大学 | 吉马酮的应用 |
| CN111617059B (zh) * | 2020-05-29 | 2023-07-25 | 广东工业大学 | 莪术二酮的应用 |
| JP7637357B2 (ja) * | 2020-09-29 | 2025-02-28 | 学校法人近畿大学 | 血管保護のためのターメリックオイルを含有する組成物、ならびにこのような組成物を含む飲食品および香料 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU83350A1 (fr) | 1981-05-08 | 1983-03-24 | Oreal | Composition destinee au traitement des fibres keratiniques a base de polymere cationique et de polymere anionique a groupements vinylsulfoniques et procede de traitement la mettant en oeuvre |
| IN162441B (ru) | 1984-12-26 | 1988-05-28 | Council Scient Ind Res | |
| US4842859A (en) * | 1986-09-08 | 1989-06-27 | Yaguang Liu | Pharmaceutical compositions for reducing hyperlipidemia and platelet-aggregation |
| US5120538A (en) * | 1990-02-05 | 1992-06-09 | Pt Darya-Varia Laboratoria | Combinations of compounds isolated from curcuma spp as anti-inflammatory agents |
| US5863938A (en) * | 1991-03-01 | 1999-01-26 | Warner Lambert Company | Antibacterial-wound healing compositions and methods for preparing and using same |
| CN1100321A (zh) * | 1994-03-27 | 1995-03-22 | 叶启智 | 灵猫香或其复方药用针剂 |
| AU2300001A (en) * | 1999-10-22 | 2001-05-08 | Board Of Trustees Of The University Of Illinois, The | Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease |
| DE10029770A1 (de) * | 2000-06-16 | 2001-12-20 | Transmit Technologietransfer | Verwendung von Curcuminen zur Behandlung von soliden Tumoren,insbesondere von Hirntumoren |
| JP2002030081A (ja) * | 2000-07-13 | 2002-01-29 | Shiseido Co Ltd | ジアリールヘプタノイド誘導体及びマトリックスメタロプロテアーゼ活性阻害剤 |
| KR20020073847A (ko) * | 2001-03-16 | 2002-09-28 | 주식회사 바이오시너젠 | 쿠르쿠민 또는 울금 추출물을 포함하는 치매 예방 및치료용 조성물 |
-
2002
- 2002-12-14 JP JP2003552313A patent/JP4695839B2/ja not_active Expired - Fee Related
- 2002-12-14 KR KR1020047009174A patent/KR101001815B1/ko not_active Expired - Fee Related
- 2002-12-14 EP EP02781641A patent/EP1453528B1/en not_active Expired - Lifetime
- 2002-12-14 CA CA2473874A patent/CA2473874C/en not_active Expired - Fee Related
- 2002-12-14 WO PCT/IB2002/005366 patent/WO2003051380A2/en active IP Right Grant
- 2002-12-14 MX MXPA04005680A patent/MXPA04005680A/es active IP Right Grant
- 2002-12-14 UA UA20040705723A patent/UA82057C2/uk unknown
- 2002-12-14 DE DE60233069T patent/DE60233069D1/de not_active Expired - Lifetime
- 2002-12-14 CN CNB028270770A patent/CN100528149C/zh not_active Expired - Fee Related
- 2002-12-14 EE EEP200400097A patent/EE05374B1/xx not_active IP Right Cessation
- 2002-12-14 GE GE5642A patent/GEP20084442B/en unknown
- 2002-12-14 BR BR0214962-1A patent/BR0214962A/pt not_active IP Right Cessation
- 2002-12-14 AU AU2002348802A patent/AU2002348802A1/en not_active Abandoned
- 2002-12-14 EA EA200400807A patent/EA007067B1/ru not_active IP Right Cessation
-
2004
- 2004-06-11 ZA ZA2004/04648A patent/ZA200404648B/en unknown
- 2004-07-02 LT LT2004060A patent/LT5284B/lt not_active IP Right Cessation
- 2004-07-13 NO NO20043000A patent/NO332066B1/no not_active IP Right Cessation
- 2004-07-13 LV LVP-04-78A patent/LV13250B/lv unknown
-
2005
- 2005-08-24 US US11/210,567 patent/US20060051438A1/en not_active Abandoned
-
2009
- 2009-05-18 US US12/467,383 patent/US20100093870A1/en not_active Abandoned
- 2009-09-07 AU AU2009212969A patent/AU2009212969B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN1615144A (zh) | 2005-05-11 |
| EP1453528A2 (en) | 2004-09-08 |
| US20060051438A1 (en) | 2006-03-09 |
| ZA200404648B (en) | 2005-11-30 |
| AU2002348802A1 (en) | 2003-06-30 |
| AU2009212969B2 (en) | 2011-06-02 |
| CA2473874C (en) | 2011-11-22 |
| LT5284B (lt) | 2005-11-25 |
| EE05374B1 (et) | 2011-02-15 |
| EP1453528B1 (en) | 2009-07-22 |
| JP4695839B2 (ja) | 2011-06-08 |
| CN100528149C (zh) | 2009-08-19 |
| LT2004060A (en) | 2005-06-27 |
| CA2473874A1 (en) | 2003-06-26 |
| BR0214962A (pt) | 2004-12-14 |
| MXPA04005680A (es) | 2004-10-15 |
| LV13250B (en) | 2006-02-20 |
| KR20040073478A (ko) | 2004-08-19 |
| WO2003051380A2 (en) | 2003-06-26 |
| NO332066B1 (no) | 2012-06-18 |
| WO2003051380A3 (en) | 2004-06-17 |
| EA007067B1 (ru) | 2006-06-30 |
| US20100093870A1 (en) | 2010-04-15 |
| UA82057C2 (en) | 2008-03-11 |
| GEP20084442B (en) | 2008-08-10 |
| JP2005516930A (ja) | 2005-06-09 |
| KR101001815B1 (ko) | 2010-12-15 |
| NO20043000L (no) | 2004-07-13 |
| AU2009212969A1 (en) | 2009-10-01 |
| EE200400097A (et) | 2004-10-15 |
| DE60233069D1 (de) | 2009-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200400807A1 (ru) | Композиция для лечения нейроцереброваскулярных нарушений | |
| Awaad et al. | Anti-inflammatory, antinociceptive and antipyretic effects of some desert plants | |
| JP2005516930A5 (ru) | ||
| EA200100872A1 (ru) | Композиция валдекоксиба | |
| BR0211119A (pt) | Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto | |
| DE60233801D1 (de) | Verfahren zur behandlung von gelenkentzündung, schmerzen und mobilitätsverlust | |
| BRPI9915822B8 (pt) | derivados de pirazolopirimidinona e sua composição farmacêutica para o tratamento de impotência | |
| EA200300776A1 (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
| EA200300293A1 (ru) | Противовоспалительные конденсированные пирролокарбазолы | |
| BRPI0407922A (pt) | derivados de isoquinolina e métodos de uso destes | |
| BRPI0415167A (pt) | composto de amina como ligandos de canal de ìon e usos dos mesmos | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| EA200701296A1 (ru) | 3,5-дизамещенные и 3,5,7-тризамещенные 3h-оксазоло- и 3h-тиазоло[4,5-d] пиримидин-2-оны и их пролекарства | |
| DE60120936D1 (de) | Behandlung von atemerkrankungen | |
| NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
| CY1111912T1 (el) | Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων | |
| EA200801711A1 (ru) | Пролекарства возбуждающих аминокислот | |
| BRPI0417376A (pt) | compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com a modulação de receptores de cb1 e sua utilização | |
| EA200201276A1 (ru) | Производные арилметиламина для использования в качестве ингибиторов триптазы | |
| PT1562954E (pt) | Antagonistas de ccr1 para o tratamento da doenca desmielinzante inflamatoria i.a. | |
| ATE263572T1 (de) | Verwendung von gastrin fragmenten oder sythetischen analogen von gastrin zur herstellung eines arzneimittels zur behandlung der helicobacter pylori assozierten störungen | |
| Airaodion et al. | Efficacy of Combined crude Extract of Curcuma longa and Moringa oleifera in the Prevention of Peptic Ulcer in Albino Rats | |
| EE200200636A (et) | Dibensoasuleeni derivaadid, nende valmistamismeetodid ja kasutamine | |
| BR9913337A (pt) | Derivados tan-1057 | |
| EA200200518A1 (ru) | Способ и композиция для лечения заболеваний легких |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |